MHCD:CA:TSX-Middlefield Healthcare Dividend ETF (CAD)

ETF | Others |

Last Closing

CAD 11.88

Change

-0.12 (-1.00)%

Market Cap

CAD 0.16B

Volume

4.00K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-04 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

+0.07 (+0.26%)

CAD 6.19B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

-0.01 (-0.01%)

CAD 5.38B
XEQT:CA iShares Core Equity Portfolio

-0.14 (-0.43%)

CAD 5.22B
PHYS-U:CA Sprott Physical Gold Trust

-0.08 (-0.37%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

-0.10 (-0.28%)

CAD 4.54B
HXT-U:CA Global X S&P/TSX 60 Index ETF

N/A

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

N/A

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

+0.01 (+0.09%)

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

-0.06 (-0.27%)

CAD 2.78B
ZMMK:CA BMO Money Market Fund ETF Seri..

+0.02 (+0.04%)

CAD 2.68B

ETFs Containing MHCD:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.82% 52% F 50% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.82% 52% F 50% F
Trailing 12 Months  
Capital Gain 13.79% 42% F 44% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 13.79% 42% F 44% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 1.99% 50% F 43% F
Dividend Return 2.07% 49% F 36% F
Total Return 0.07% 43% F 12% F
Risk Return Profile  
Volatility (Standard Deviation) 5.47% 74% C 89% A-
Risk Adjusted Return 37.79% 57% F 55% F
Market Capitalization 0.16B 73% C 42% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.